Skip to main content
Nanobiotix logo

Nanobiotix — Investor Relations & Filings

Ticker · NANO ISIN · FR0011341205 LEI · 969500667RSYIH8YL895 PA Manufacturing
Open in API
Filings indexed 791 across all filing types
Latest filing 2025-09-08 Major Shareholding Noti…
Country FR France
Listing PA NANO

About Nanobiotix

https://www.nanobiotix.com/

Nanobiotix is a late-stage clinical biotechnology company pioneering a physics-based approach to cancer treatment through the development of nanotherapeutics. Its lead product candidate, NBTXR3, is a potential first-in-class radioenhancer designed to be injected directly into a tumor. When activated by radiotherapy, NBTXR3 amplifies the radiation dose within the tumor, aiming to destroy cancer cells more effectively without increasing exposure to surrounding healthy tissues. This process is also intended to prime an immune response to target metastatic tumors. The company is developing NBTXR3 for broad application across various solid tumors, with an initial focus on head, neck, and lung cancers through a global licensing agreement with Janssen Pharmaceutica NV.

Recent filings

Filing Released Lang Actions
Franchissement de seuils
Major Shareholding Notification Classification · 100% confidence The document is a formal notification of a major shareholding threshold crossing (franchissement de seuils) filed with the AMF (Autorité des marchés financiers). It details that The Goldman Sachs Group, Inc. has crossed the 5% ownership threshold in the company NANOBIOTIX. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-09-08 French
Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
Regulatory Filings Classification · 100% confidence The document is a press release announcing that Nanobiotix will participate in an upcoming investor conference (H.C. Wainwright 27th Annual Global Investment). It provides details about the event, the participants, and how to access the webcast. It does not contain the actual presentation slides or financial reports, but rather serves as a notification of an upcoming investor relations event. As it does not fit into specific categories like 'Investor Presentation' (which would be the slides themselves) or 'Earnings Release', and is a general regulatory/corporate announcement, it is best classified as a Regulatory Filing (RNS).
2025-09-02 French
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Regulatory Filings Classification · 100% confidence The document is a press release announcing that company management will participate in an upcoming investor conference (H.C. Wainwright 27th Annual Global Investment Conference). It provides details on the event, speakers, and a link to the webcast. Since it is a general regulatory announcement regarding company activities that does not fit into specific categories like financial reports or M&A, it is classified as a Regulatory Filing (RNS).
2025-09-02 English
Voting Rights and Shares Capital of the Company
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release titled 'VOTING RIGHTS AND SHARES CAPITAL OF THE COMPANY'. It provides a monthly update on the number of outstanding shares and voting rights in accordance with French regulatory requirements (AMF). This type of disclosure is a standard regulatory filing regarding share capital and voting rights, which does not fit into specific categories like 'Major Shareholding Notification' (which is for third-party threshold crossings) or 'Share Issue' (which is for specific capital changes). Therefore, it is classified as a general Regulatory Filing (RNS).
2025-08-27 English
Franchissements de seuils
Major Shareholding Notification Classification · 100% confidence The document is an official notice from the AMF (Autorité des marchés financiers) regarding 'Déclarations de franchissements de seuils' (threshold crossing declarations). It details changes in shareholding by The Goldman Sachs Group, Inc. in the company NANOBIOTIX, specifically crossing the 5% threshold. This falls under the category of Major Shareholding Notification (MRQ).
2025-08-11 French
Franchissements de seuils
Major Shareholding Notification Classification · 100% confidence The document is an official notification regarding the crossing of shareholding thresholds (franchissements de seuils) by The Goldman Sachs Group, Inc. in the company NANOBIOTIX. It cites specific articles of the French Commercial Code (article L. 233-7) and is issued in the context of AMF (Autorité des marchés financiers) regulations. This type of disclosure is specifically categorized as a Major Shareholding Notification.
2025-08-11 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.